DK1601673T3 - Kondenserede heterocykler og anvendelser af disse - Google Patents
Kondenserede heterocykler og anvendelser af disseInfo
- Publication number
- DK1601673T3 DK1601673T3 DK04717339T DK04717339T DK1601673T3 DK 1601673 T3 DK1601673 T3 DK 1601673T3 DK 04717339 T DK04717339 T DK 04717339T DK 04717339 T DK04717339 T DK 04717339T DK 1601673 T3 DK1601673 T3 DK 1601673T3
- Authority
- DK
- Denmark
- Prior art keywords
- applications
- condensed heterocycles
- heterocycles
- condensed
- Prior art date
Links
- 125000000623 heterocyclic group Chemical group 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0300627A SE0300627D0 (sv) | 2003-03-07 | 2003-03-07 | Novel fused heterocycles and uses therof |
SE0301138A SE0301138D0 (sv) | 2003-04-15 | 2003-04-15 | Novel fused heterocycles and uses thereof |
SE0301697A SE0301697D0 (sv) | 2003-06-10 | 2003-06-10 | Novel fused heterocycles and uses thereof |
SE0302826A SE0302826D0 (sv) | 2003-10-24 | 2003-10-24 | Novel fused heterocycles and uses thereof |
PCT/SE2004/000304 WO2004078758A1 (fr) | 2003-03-07 | 2004-03-04 | Nouveaux heterocycles fusionnes et leurs utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1601673T3 true DK1601673T3 (da) | 2009-08-24 |
Family
ID=32966643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04717339T DK1601673T3 (da) | 2003-03-07 | 2004-03-04 | Kondenserede heterocykler og anvendelser af disse |
Country Status (25)
Country | Link |
---|---|
US (1) | US20060270689A1 (fr) |
EP (1) | EP1601673B1 (fr) |
JP (2) | JP3947758B2 (fr) |
KR (1) | KR20050107784A (fr) |
AR (1) | AR043487A1 (fr) |
AT (1) | ATE433448T1 (fr) |
AU (1) | AU2004218080B2 (fr) |
BR (1) | BRPI0408150A (fr) |
CA (1) | CA2518224C (fr) |
CY (1) | CY1109300T1 (fr) |
DE (1) | DE602004021477D1 (fr) |
DK (1) | DK1601673T3 (fr) |
ES (1) | ES2326647T3 (fr) |
HK (1) | HK1084390A1 (fr) |
IS (1) | IS8036A (fr) |
MX (1) | MXPA05009577A (fr) |
MY (1) | MY141583A (fr) |
NO (1) | NO20054340L (fr) |
NZ (1) | NZ542227A (fr) |
PL (1) | PL1601673T3 (fr) |
PT (1) | PT1601673E (fr) |
SI (1) | SI1601673T1 (fr) |
TW (1) | TW200510427A (fr) |
UA (1) | UA81470C2 (fr) |
WO (1) | WO2004078758A1 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2485148A1 (fr) | 2002-05-09 | 2003-11-20 | Cytokinetics, Inc. | Composes, compositions et procedes |
WO2006018628A1 (fr) * | 2003-03-07 | 2006-02-23 | Astrazeneca Ab | Enantiomeres de pyrimidones fusionnes selectionnes et utilisations dans le traitement et la prevention du cancer |
EP1608317B1 (fr) * | 2003-03-25 | 2012-09-26 | Takeda Pharmaceutical Company Limited | Inhibiteurs de dipeptidyle peptidase |
US7022850B2 (en) | 2003-05-22 | 2006-04-04 | Bristol-Myers Squibb Co. | Bicyclicpyrimidones and their use to treat diseases |
KR20070046176A (ko) * | 2004-08-18 | 2007-05-02 | 아스트라제네카 아베 | 특정 융합 피리미돈의 거울상이성질체 및 이의 암 치료 및예방에 있어서의 용도 |
JP2008509976A (ja) * | 2004-08-18 | 2008-04-03 | アストラゼネカ アクチボラグ | 選択された縮合複素環及びその使用 |
US20080102068A1 (en) * | 2005-01-19 | 2008-05-01 | Coleman Paul J | Mitotic Kinesin Inhibitors |
DE102005011822A1 (de) * | 2005-03-15 | 2006-09-21 | Merck Patent Gmbh | Phthalazinone |
DE102005027168A1 (de) | 2005-06-13 | 2006-12-14 | Merck Patent Gmbh | Tetrahydrochinoline |
CN101842100A (zh) | 2007-06-21 | 2010-09-22 | 诺伊罗纳森特公司 | 使用异噻唑并嘧啶酮刺激神经发生和抑制神经元变性的方法和组合物 |
WO2009001214A2 (fr) * | 2007-06-28 | 2008-12-31 | Pfizer Products Inc. | Dérivés de thieno[2,3-d]pyrimidin-4(3h)-one, d'isoxazolo[5,4-d]pyrimidin-4(5h)-one et d'isothiazolo[5,4-d]pyrimidin-4(5h)-one utilisés comme antagonistes du récepteur du calcium |
CN114478429B (zh) * | 2020-11-13 | 2023-11-17 | 中国科学院大连化学物理研究所 | 一种3-烷硫基异噻唑衍生物及其合成方法 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7230000B1 (en) * | 1999-10-27 | 2007-06-12 | Cytokinetics, Incorporated | Methods and compositions utilizing quinazolinones |
US6545004B1 (en) * | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
EA007538B1 (ru) * | 2000-12-11 | 2006-10-27 | Туларик Инк. | Антагонисты cxcr3 |
US6809102B2 (en) * | 2001-03-29 | 2004-10-26 | Bristol-Myers Squibb Company | Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
US7060705B2 (en) * | 2001-11-07 | 2006-06-13 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
US6753428B2 (en) * | 2001-11-20 | 2004-06-22 | Cytokinetics, Inc. | Process for the racemization of chiral quinazolinones |
WO2003049678A2 (fr) * | 2001-12-06 | 2003-06-19 | Merck & Co., Inc. | Inhibiteurs mitotiques de la kinesine |
EP1465896A4 (fr) * | 2001-12-06 | 2006-01-11 | Merck & Co Inc | Inhibiteurs mitotiques de la kinesine |
JP4597519B2 (ja) * | 2001-12-06 | 2010-12-15 | メルク・シャープ・エンド・ドーム・コーポレイション | 有糸分裂キネシン阻害薬 |
EP1481077B1 (fr) * | 2001-12-06 | 2009-11-04 | Merck & Co., Inc. | Inhibiteurs mitotiques de la kin sine |
US7262186B2 (en) * | 2001-12-06 | 2007-08-28 | Merck & Co., Inc. | Substituted pyrazolo[3,4-d] pyrimidinones as a mitotic kinesin inhibitor |
BR0309278A (pt) * | 2002-04-17 | 2005-04-26 | Cytokinetics Inc | Composto, composição, métodos para modular a atividade da cinesina ksp, para inibir a ksp, para o tratamento de uma doença proliferativa celular, e, uso de um composto |
CA2485148A1 (fr) * | 2002-05-09 | 2003-11-20 | Cytokinetics, Inc. | Composes, compositions et procedes |
AU2003270015A1 (en) * | 2002-05-09 | 2003-12-02 | Cytokinetics, Inc. | Compounds, compositions, and methods |
AU2003265242A1 (en) * | 2002-05-23 | 2003-12-22 | Cytokinetics, Inc. | Compounds, compositions, and methods |
US6949538B2 (en) * | 2002-07-17 | 2005-09-27 | Cytokinetics, Inc. | Compounds, compositions, and methods |
US7022850B2 (en) * | 2003-05-22 | 2006-04-04 | Bristol-Myers Squibb Co. | Bicyclicpyrimidones and their use to treat diseases |
US7345046B2 (en) * | 2003-05-30 | 2008-03-18 | Chiron Corporation | Heteroaryl-fused pyrimidinyl compounds as anticancer agents |
MXPA05013142A (es) * | 2003-06-20 | 2006-03-17 | Chiron Corp | Compuestos de piridinio [1,2-a]pirimidin-4-ona como agentes anticancer. |
EP1670456A2 (fr) * | 2003-10-06 | 2006-06-21 | Cytokinetics, Inc. | Composes, compositions et procedes |
US20050148593A1 (en) * | 2003-11-07 | 2005-07-07 | Gustave Bergnes | Compounds, compositions, and methods |
US20050158320A1 (en) * | 2003-11-12 | 2005-07-21 | Nichols M. J. | Combinations for the treatment of proliferative diseases |
US7501416B2 (en) * | 2004-02-06 | 2009-03-10 | Bristol-Myers Squibb Company | Quinoxaline compounds and methods of using them |
AU2005233576A1 (en) * | 2004-04-06 | 2005-10-27 | Novartis Vaccines And Diagnostics, Inc. | Mitotic kinesin inhibitors |
MX2007004699A (es) * | 2004-10-19 | 2007-06-14 | Novartis Vaccines & Diagnostic | Derivados de indol y bencimidazol. |
-
2004
- 2004-03-04 CA CA2518224A patent/CA2518224C/fr not_active Expired - Fee Related
- 2004-03-04 DE DE602004021477T patent/DE602004021477D1/de not_active Expired - Lifetime
- 2004-03-04 EP EP04717339A patent/EP1601673B1/fr not_active Expired - Lifetime
- 2004-03-04 BR BRPI0408150-1A patent/BRPI0408150A/pt not_active IP Right Cessation
- 2004-03-04 ES ES04717339T patent/ES2326647T3/es not_active Expired - Lifetime
- 2004-03-04 MY MYPI20040755A patent/MY141583A/en unknown
- 2004-03-04 MX MXPA05009577A patent/MXPA05009577A/es active IP Right Grant
- 2004-03-04 NZ NZ542227A patent/NZ542227A/en not_active IP Right Cessation
- 2004-03-04 SI SI200431186T patent/SI1601673T1/sl unknown
- 2004-03-04 JP JP2006507939A patent/JP3947758B2/ja not_active Expired - Fee Related
- 2004-03-04 WO PCT/SE2004/000304 patent/WO2004078758A1/fr active Application Filing
- 2004-03-04 PT PT04717339T patent/PT1601673E/pt unknown
- 2004-03-04 AT AT04717339T patent/ATE433448T1/de active
- 2004-03-04 US US10/548,138 patent/US20060270689A1/en not_active Abandoned
- 2004-03-04 KR KR1020057016722A patent/KR20050107784A/ko not_active Application Discontinuation
- 2004-03-04 AU AU2004218080A patent/AU2004218080B2/en not_active Ceased
- 2004-03-04 DK DK04717339T patent/DK1601673T3/da active
- 2004-03-04 PL PL04717339T patent/PL1601673T3/pl unknown
- 2004-03-05 AR ARP040100701A patent/AR043487A1/es not_active Application Discontinuation
- 2004-03-05 TW TW093105906A patent/TW200510427A/zh unknown
- 2004-04-03 UA UAA200509430A patent/UA81470C2/uk unknown
-
2005
- 2005-09-19 IS IS8036A patent/IS8036A/is unknown
- 2005-09-20 NO NO20054340A patent/NO20054340L/no unknown
-
2006
- 2006-04-18 HK HK06104612.4A patent/HK1084390A1/xx not_active IP Right Cessation
- 2006-07-25 JP JP2006201461A patent/JP2007063257A/ja active Pending
-
2009
- 2009-08-10 CY CY20091100845T patent/CY1109300T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP2006519853A (ja) | 2006-08-31 |
AU2004218080A1 (en) | 2004-09-16 |
JP2007063257A (ja) | 2007-03-15 |
WO2004078758A1 (fr) | 2004-09-16 |
MY141583A (en) | 2010-05-14 |
AU2004218080B2 (en) | 2008-01-03 |
JP3947758B2 (ja) | 2007-07-25 |
PL1601673T3 (pl) | 2009-10-30 |
NZ542227A (en) | 2008-12-24 |
ATE433448T1 (de) | 2009-06-15 |
MXPA05009577A (es) | 2005-12-12 |
CA2518224C (fr) | 2010-06-15 |
SI1601673T1 (sl) | 2009-10-31 |
IS8036A (is) | 2005-09-19 |
AR043487A1 (es) | 2005-08-03 |
NO20054340L (no) | 2005-09-26 |
DE602004021477D1 (de) | 2009-07-23 |
PT1601673E (pt) | 2009-07-29 |
US20060270689A1 (en) | 2006-11-30 |
UA81470C2 (en) | 2008-01-10 |
CA2518224A1 (fr) | 2004-09-16 |
EP1601673B1 (fr) | 2009-06-10 |
KR20050107784A (ko) | 2005-11-15 |
BRPI0408150A (pt) | 2006-03-21 |
TW200510427A (en) | 2005-03-16 |
EP1601673A1 (fr) | 2005-12-07 |
ES2326647T3 (es) | 2009-10-16 |
HK1084390A1 (en) | 2006-07-28 |
CY1109300T1 (el) | 2014-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS2989B (is) | Pólýalkýlenfjölliðusambönd og gagn af þeim | |
DK1478648T3 (da) | Phosphorholdige forbindelser og anvendelser deraf | |
DK3620171T3 (da) | Anti-GM-CSF-antistoffer og anvendelser af disse | |
DK1673460T3 (da) | Rekombinante vacciner og anvendelse af disse | |
DK2418220T3 (da) | Interferon-alpha-antistoffer og anvendelser deraf | |
NO20055018D0 (no) | Anti-amyolide antistoffer, sammensetninger, fremgangsmater og anvendelser | |
NO20053771L (no) | Ringromsfluider og fremgangsmater for plassering av de samme | |
DK1642499T3 (da) | Fungicidblandinger på basis af prothioconazol og picozystrobin | |
DK1979378T3 (da) | Ny samling af HCDR3 områder og anvendelser derfor | |
DK1691837T3 (da) | IP-10-antistoffer og anvendelse heraf | |
SE0303074L (sv) | Foganordning | |
DK1904104T3 (da) | SP35-antistoffer og anvendelser heraf | |
DE60318105D1 (de) | Pipeline-coprozessor | |
DK1591446T3 (da) | Thienopyrimidinforbindelser og anvendelse deraf. | |
DK1390389T3 (da) | Cripto-blokerende antistoffer og anvendelser deraf | |
DE602004024728D1 (de) | Schiebeelement | |
DK1814977T3 (da) | Arthrospira-baserede sammensætninger og anvendelser deraf | |
ATE423117T1 (de) | Heterocyclische 7-aminoalkylidenylchinolone und - naphthyridone | |
IS8036A (is) | Nýir sambræddir heteróhringir og notkun þeirra | |
DK1562918T3 (da) | Substituerede benzoxazinoner og anvendelser deraf | |
DK1601744T3 (da) | Forgasningsapparat og fremgangsmåde | |
IS8489A (is) | Umritunarstillar og aðferðir þeirra | |
DK1654276T3 (da) | Svamperesistente planter og anvendelser af disse | |
FI20031690A0 (fi) | Elektroninen rannelaite | |
FR2857710B1 (fr) | Joint homocinetique compact |